Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-22

Clinical Trial Update: High Altitude Residents With High Altitude Pulmonary Hypertension (HAPH), SDB Assessed at HA (3200 m) vs LA (760 m) [NA]

View source ↗

Summary

A completed clinical trial from the University of Zurich evaluated sleep-disordered breathing in people with high-altitude pulmonary hypertension by comparing a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Zurich | Conditions: High Altitude Pulmonary Hypertension | NA | Status: COMPLETED